BMY
必治妥 BRISTOL MYERS SQUIBB CO
-0.18 (-0.28%)63.43USD3.7M成交股數130B市值13.9本益比(近四季)2.6股價營收比+5.7%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 13.0B+16% | 11.5B-7% | 12.2B+3% | 12.3B+1% | 11.2B-6% | 12.3B+13% | 11.9B+6% | 12.2B+8% | 11.9B | 11.0B | 11.2B | 11.3B |
| 營業成本 | 3.7B | 3.4B | 3.4B | 3.4B | 3.0B | 4.8B | 3.0B | 3.3B | 2.9B | 2.5B | 2.9B | 2.6B |
| 毛利 | 9.2B+13% | 8.1B+7% | 8.8B-2% | 8.9B-0% | 8.2B-9% | 7.5B-11% | 8.9B+7% | 8.9B+2% | 8.9B | 8.5B | 8.4B | 8.8B |
| 毛利率 | 71.3% | 70.2% | 71.9% | 72.5% | 72.9% | 61.0% | 75.1% | 73.2% | 75.3% | 77.1% | 74.4% | 77.4% |
| 研發費用 | 3.0B | 2.6B | 2.5B | 2.6B | 2.3B | 3.2B | 2.4B | 2.9B | 2.7B | 2.2B | 2.3B | 2.3B |
| 銷售管理費用 | 1.8B | 1.6B | 1.8B | 1.7B | 1.6B | 2.1B | 2.0B | 1.9B | 2.4B | 2.0B | 1.9B | 1.8B |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | 3.3B+35% | 2.7B+3618% | 2.2B+82% | 1.3B-22% | 2.5B-121% | 72.0M-96% | 1.2B-42% | 1.7B-26% | −11.9B | 1.9B | 2.1B | 2.3B |
| 淨利率 | 25.6% | 23.3% | 18.0% | 10.7% | 21.9% | 0.6% | 10.2% | 13.8% | -100.4% | 17.6% | 18.5% | 20.0% |
| 稀釋 EPS | 1.62+35% | 1.31+2520% | 1.08+80% | 0.64-23% | 1.20-120% | 0.05-95% | 0.60-39% | 0.83-22% | -5.89 | 0.93 | 0.99 | 1.07 |
| 稀釋股數 | 2.05B | 2.05B | 2.04B | 2.04B | 2.04B | 2.03B | 2.03B | 2.03B | 2.02B | 2.06B | 2.10B | 2.11B |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 8.7B | 9.6B | 15.7B | 12.6B | 10.9B | 10.3B | 7.9B | 6.3B | 9.3B | 7.5B | 8.4B | 9.0B |
| 應收帳款 | 9.1B | 7.9B | 9.6B | 9.7B | 9.1B | 9.0B | 9.3B | 9.7B | 8.8B | 8.4B | 8.1B | 7.9B |
| 存貨 | 2.7B | 2.8B | 2.8B | 2.7B | 2.7B | 2.6B | 3.3B | 3.1B | 3.0B | 2.4B | 2.4B | 2.6B |
| 總資產 | 87.6B | 86.5B | 96.9B | 94.7B | 92.4B | 92.6B | 93.7B | 94.6B | 99.0B | 91.3B | 93.5B | 94.3B |
| 有息負債 | 42.1B | 42.2B | 44.5B | 44.5B | 46.2B | 47.6B | 48.7B | 48.9B | 49.5B | 32.1B | 34.7B | 35.1B |
| 總負債 | 65.3B | 66.4B | 78.3B | 77.2B | 75.0B | 76.2B | 76.5B | 77.6B | 82.5B | 62.2B | 61.5B | 62.4B |
| 股東權益 | 22.3B | 20.1B | 18.6B | 17.4B | 17.4B | 16.3B | 17.1B | 17.0B | 16.5B | 29.0B | 32.0B | 31.8B |
| 負債比 | 74.5% | 76.8% | 80.8% | 81.5% | 81.1% | 82.3% | 81.6% | 82.0% | 83.3% | 68.2% | 65.7% | 66.2% |
| 淨現金(現金 − 有息負債) | −33.4B | −32.6B | −28.7B | −31.9B | −35.3B | −37.3B | −40.8B | −42.6B | −40.2B | −24.6B | −26.3B | −26.1B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 1.1B | – | – | 2.0B-31% | – | – | – | 2.8B | – | – | 3.0B |
| 資本支出 | – | 347M | – | – | 260M | – | – | – | 284M | – | – | 278M |
| 自由現金流 | – | 757M | – | – | 1.7B-34% | – | – | – | 2.6B | – | – | 2.7B |
| 折舊攤銷 | – | 594M | – | – | 1.0B | – | – | – | 2.5B | – | – | 2.4B |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 0.00 | – | – | 250M |
| 現金股利 | – | 1.3B | – | – | 1.3B | – | – | – | 1.2B | – | – | 1.2B |
| 自由現金流率 | – | 6.6% | – | – | 15.1% | – | – | – | 21.5% | – | – | 23.7% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 48.2B
| 美國 | 33.3B | 69.1% | -2.4% |
|---|---|---|---|
| 美國以外 | 13.8B | 28.7% | +4.8% |
| Other Region | 1.1B | 2.3% | +9.1% |
產品／服務2025 年度 · 31.8B
| Legacy Brands | 21.8B | 68.4% | -15.4% |
|---|---|---|---|
| Opdivo | 10.0B | 31.6% | +8.0% |
| Sales Revenue Gross 小計 | 88.1B | 276.7% | +5.3% |
| Net Product Sales 小計 | 46.8B | 146.9% | 0.0% |
| Growth Brands 小計 | 26.4B | 83.0% | +17.0% |
| Eliquis 小計 | 14.4B | 45.4% | +8.3% |
| Orencia 小計 | 3.7B | 11.6% | +0.6% |
| Revlimid 小計 | 3.0B | 9.3% | -48.9% |
| Yervoy 小計 | 2.9B | 9.1% | +14.6% |
| Pomalyst Imnovid 小計 | 2.7B | 8.6% | -22.9% |
| Reblozyl 小計 | 2.3B | 7.3% | +31.2% |
| Other Growth Brands 小計 | 1.9B | 6.0% | +17.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 48.2B | -0.2% | 7.1B | 14.6% | 3.46 | 12.8B |
| FY2024 | 48.3B | +7.3% | −8.9B | -18.5% | -4.41 | 13.9B |
| FY2023 | 45.0B | -2.5% | 8.0B | 17.8% | 3.86 | 12.7B |
| FY2022 | 46.2B | -0.5% | 6.3B | 13.7% | 2.95 | 11.9B |
| FY2021 | 46.4B | +9.1% | 7.0B | 15.1% | 3.12 | 15.2B |
| FY2020 | 42.5B | +62.6% | −9.0B | -21.2% | -3.99 | 13.3B |
| FY2019 | 26.1B | +15.9% | 3.4B | 13.2% | 2.01 | 7.4B |
| FY2018 | 22.6B | – | 4.9B | 21.8% | 3.01 | 6.1B |